Skip to content
Home
Product
Technology
Education
Clinical Trials
Company
News
Contact Us
Home
Product
Technology
Education
Clinical Trials
Company
News
Contact Us
News
Clinical Trial Demonstrates Accurate Non-Invasive Detection of In Vivo Biologic Activity in Melanomas by the Orlucent® Skin Fluorescent Imaging System
January 20, 2026
READ MORE
Stromal Tumor Environment May Be Early Indicator of Melanoma Progression
May 15, 2025
READ MORE
Orlucent® Receives California Food and Drug Branch Manufacturing License
March 9, 2025
READ MORE
Orlucent® Supports Research on Updated Criteria for Histopathologic Scoring and Grading of Melanocytic Dysplasia
November 4, 2024
READ MORE
Orlucent® Proof of Concept Activity Image Featured in Cover Story of Pigment Cell & Melanoma Research
May 8, 2024
READ MORE
Orlucent® Featured in Clinical Lab Products Magazine
February 14, 2024
READ MORE
Orlucent® Demonstrates Accurate, Non-Invasive Detection In Vivo of Melanoma-Related Activity Using First-in-Kind Handheld Imaging System
January 16, 2024
READ MORE
Orlucent® Achieves Renewal of ISO 13485:2016 Certification
December 17, 2023
READ MORE
Discovery of Distinctive Set of Gene Expression Patterns Changes Understanding of Atypical Mole Development and Early Melanoma
June 22, 2023
READ MORE
Orlucent® Receives FDA Breakthrough Device Designation for Handheld Mole Imaging System
May 25, 2023
READ MORE
SHOW MORE
